Drugs & Targets Strata Oncology, Carbone Cancer Center integrate StrataNGS test results with Epic Genomics Module September 16, 2022Vol.48 No.33
Drugs & Targets Indivumed and CELLphenomics form partnership for improved patient care in EU-funded project September 16, 2022Vol.48 No.33
Conversation with The Cancer Letter How Augusto Ochoa stumbled into community oncology—and built Gulf South Minority NCORP September 09, 2022Vol.48 No.32By Paul Goldberg
Fate of Illumina-GRAIL $7.1B merger uncertain as (1) EU blocks it, (2) FTC administrative law judge jettisons agency’s opposition September 09, 2022Vol.48 No.32By Paul Goldberg
NCI Lowy: NCI to focus on multi-cancer detection tests, diversity in workforce, clinical trials September 09, 2022Vol.48 No.32By Matthew Bin Han Ong
In Brief Fred Hutchinson Cancer Center receives $78M gift from Stuart and Molly Sloan to support precision oncology September 09, 2022Vol.48 No.32
In Brief Loïc Le Marchand awarded 2022 AACR distinguished lectureship on the science of cancer health disparities September 09, 2022Vol.48 No.32
In Brief California State Legislature passes landmark cancer care access bill September 09, 2022Vol.48 No.32
In Brief Kansas governor honors KU Cancer Center’s Comprehensive Cancer Center designation September 09, 2022Vol.48 No.32
In Brief MD Anderson’s Allison Institute forms scientific advisory board September 09, 2022Vol.48 No.32
